These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 30984396)

  • 21. [A pediatric case of pneumococcal meningitis due to Streptococcus pneumoniae serotype 35F].
    Kara SS; Polat M; Tapisiz A; Nar Otgun S; Tezer H
    Mikrobiyol Bul; 2014 Apr; 48(2):346-50. PubMed ID: 24819273
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of 13-valent pneumococcal conjugate vaccination on invasive pneumococcal disease in children under 15 years old in Madrid, Spain, 2007 to 2016: The HERACLES clinical surveillance study.
    Picazo JJ; Ruiz-Contreras J; Casado-Flores J; Negreira S; Baquero-Artigao F; Hernández-Sampelayo T; Otheo E; Amo MD; Méndez C;
    Vaccine; 2019 Apr; 37(16):2200-2207. PubMed ID: 30902478
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Change in Bacterial Causes of Community-Acquired Parapneumonic Effusion and Pleural Empyema in Children 6 Years After 13-Valent Pneumococcal Conjugate Vaccine Implementation.
    Madhi F; Levy C; Morin L; Minodier P; Dubos F; Zenkhri F; Dommergues MA; Mezgueldi E; Levieux K; ; Béchet S; Varon E; Cohen R;
    J Pediatric Infect Dis Soc; 2019 Nov; 8(5):474-477. PubMed ID: 30407519
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness of the 13-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in South African children: a case-control study.
    Cohen C; von Mollendorf C; de Gouveia L; Lengana S; Meiring S; Quan V; Nguweneza A; Moore DP; Reubenson G; Moshe M; Madhi SA; Eley B; Hallbauer U; Finlayson H; Varughese S; O'Brien KL; Zell ER; Klugman KP; Whitney CG; von Gottberg A;
    Lancet Glob Health; 2017 Mar; 5(3):e359-e369. PubMed ID: 28139443
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of the pediatric 13-valent pneumococcal conjugate vaccine on serotype distribution and clinical characteristics of pneumococcal pneumonia in adults: The Japan Pneumococcal Vaccine Effectiveness Study (J-PAVE).
    Sando E; Suzuki M; Furumoto A; Asoh N; Yaegashi M; Aoshima M; Ishida M; Hamaguchi S; Otsuka Y; Morimoto K
    Vaccine; 2019 May; 37(20):2687-2693. PubMed ID: 30975569
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pneumococcal disease: emergence of serotypes 19A and 7F following conjugate pneumococcal vaccination in a Mexican hospital.
    Chacon-Cruz E; Velazco-Mendez Y; Navarro-Alvarez S; Rivas-Landeros RM; Volker ML; Lopez-Espinoza G
    J Infect Dev Ctries; 2012 Jun; 6(6):516-20. PubMed ID: 22706195
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microbiological characteristics and outcomes of children with pleural empyema admitted to a tertiary hospital in southeast China, 2009-2018.
    Zhang X; Zhang H
    Turk J Pediatr; 2021; 63(6):994-1003. PubMed ID: 35023649
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Streptococcus pneumoniae Serotypes Identified in Mexican Children with Invasive Disease Before and After the Introduction of PCV7 (1993-2012).
    Echaniz-Aviles G; Soto-Nogueron A; Miranda-Novales G; Carnalla-Barajas MN; Velazquez-Meza ME; Solórzano-Santos F;
    Arch Med Res; 2015 Feb; 46(2):149-53. PubMed ID: 25743930
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aetiology of paediatric pneumonia with effusion in the Dominican Republic and the potential impact of pneumococcal conjugate vaccines.
    Feris-Iglesias J; Fernández J; Sánchez J; Pimenta F; Peña C; Coradin H; Perez-Then E; Peinado M; Floren A; Del Moral T; Erdman D; da Gloria Carvalho M; Verani JR
    Pneumonia (Nathan); 2014; 4():8-15. PubMed ID: 29725575
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Necrotizing pneumonia among Italian children in the pneumococcal conjugate vaccine era.
    Carloni I; Ricci S; Rubino C; Cobellis G; Rinaldelli G; Azzari C; de Benedictis FM
    Pediatr Pulmonol; 2021 May; 56(5):1127-1135. PubMed ID: 33442941
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Invasive Streptococcus pneumoniae isolates from pediatric population in Argentina for the period 2006-2019. Temporal progression of serotypes distribution and antibiotic resistance.
    Zintgraff J; Gagetti P; Napoli D; Sanchez Eluchans N; Irazu L; Moscoloni M; ; Regueira M; Lara CS; Corso A
    Vaccine; 2022 Jan; 40(3):459-470. PubMed ID: 34920903
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characteristics and Serotype Distribution of Childhood Cases of Invasive Pneumococcal Disease Following Pneumococcal Conjugate Vaccination in England and Wales, 2006-2014.
    Oligbu G; Collins S; Andrews N; Sheppard CL; Fry NK; Slack MPE; Borrow R; Ladhani SN
    Clin Infect Dis; 2017 Oct; 65(7):1191-1198. PubMed ID: 29309553
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serotype distribution and antimicrobial susceptibilities of nasopharyngeal isolates of Streptococcus pneumoniae from healthy children in the 13-valent pneumococcal conjugate vaccine era.
    Zuccotti G; Mameli C; Daprai L; Garlaschi ML; Dilillo D; Bedogni G; Faccini M; Gramegna M; Torresani E; ; Ballerini E; Benincaso A; Bonvissuto M; Bricalli D; Brioschi M; Calloni CS; Camiletti MI; Colella G; De Angelis L; Decarlis S; Di Nello F; Dozzi M; Galli E; Gandini V; Giuliani MG; Laviola F; Loda B; Macedoni M; Mazzucchi E; Metta MG; Moscatiello A; Nannini P; Petruzzi M; Picicco D; Picciotti M; Pisanelli S; Porta N; Ramponi G; Redaelli F; Rubini R; Sala N; Saitta V; Scelza G; Tiso RM; Tomasetto M; Torcoletti M; Travaini M; Valentini M; Vessia C
    Vaccine; 2014 Jan; 32(5):527-34. PubMed ID: 24342249
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of 13-Valent Pneumococcal Conjugate Vaccine on Pneumococcal Meningitis, Burkina Faso, 2016-2017.
    Soeters HM; Kambiré D; Sawadogo G; Ouédraogo-Traoré R; Bicaba B; Medah I; Sangaré L; Ouédraogo AS; Ouangraoua S; Yaméogo I; Congo-Ouédraogo M; Ky Ba A; Aké F; Srinivasan V; Novak RT; McGee L; Whitney CG; Van Beneden C
    J Infect Dis; 2019 Oct; 220(220 Suppl 4):S253-S262. PubMed ID: 31671444
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of pneumococcal conjugate vaccines on burden of invasive pneumococcal disease and serotype distribution of Streptococcus pneumoniae isolates: an overview from Kuwait.
    Mokaddas E; Albert MJ
    Vaccine; 2012 Dec; 30 Suppl 6():G37-40. PubMed ID: 23228356
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectiveness of the seven-valent and thirteen-valent pneumococcal conjugate vaccines in England: The indirect cohort design, 2006-2018.
    Andrews N; Kent A; Amin-Chowdhury Z; Sheppard C; Fry N; Ramsay M; Ladhani SN
    Vaccine; 2019 Jul; 37(32):4491-4498. PubMed ID: 31272872
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expansion of serotype coverage in the universal pediatric vaccination calendar: short-term effects on age- and serotype-dependent incidence of invasive pneumococcal clinical presentations in Madrid, Spain.
    Picazo J; Ruiz-Contreras J; Casado-Flores J; Negreira S; García-de-Miguel MJ; Hernández-Sampelayo T; Otheo E; Méndez C;
    Clin Vaccine Immunol; 2013 Oct; 20(10):1524-30. PubMed ID: 23925887
    [TBL] [Abstract][Full Text] [Related]  

  • 38. General health, otitis media, nasopharyngeal carriage and middle ear microbiology in Northern Territory Aboriginal children vaccinated during consecutive periods of 10-valent or 13-valent pneumococcal conjugate vaccines.
    Leach AJ; Wigger C; Beissbarth J; Woltring D; Andrews R; Chatfield MD; Smith-Vaughan H; Morris PS
    Int J Pediatr Otorhinolaryngol; 2016 Jul; 86():224-32. PubMed ID: 27260611
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in empyema among U.S. children in the pneumococcal conjugate vaccine era.
    Wiese AD; Griffin MR; Zhu Y; Mitchel EF; Grijalva CG
    Vaccine; 2016 Dec; 34(50):6243-6249. PubMed ID: 27832918
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Burden of vaccine-preventable pneumococcal disease in hospitalized adults: A Canadian Immunization Research Network (CIRN) Serious Outcomes Surveillance (SOS) network study.
    LeBlanc JJ; ElSherif M; Ye L; MacKinnon-Cameron D; Li L; Ambrose A; Hatchette TF; Lang AL; Gillis H; Martin I; Andrew MK; Boivin G; Bowie W; Green K; Johnstone J; Loeb M; McCarthy A; McGeer A; Moraca S; Semret M; Stiver G; Trottier S; Valiquette L; Webster D; McNeil SA;
    Vaccine; 2017 Jun; 35(29):3647-3654. PubMed ID: 28554501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.